Weiwei Wang

机构：Aviation Industry Corporation of China (China), Cliniques Universitaires Saint-Luc, Anhui Medical University, Nankai University, Kementerian Pendidikan Malaysia, State Key Laboratory of Medicinal Chemical Biology, UCLouvain

发表论文 386 篇 · 总被引 13306 次 · h-index 62

代表论文

pH-responsive sparfloxacin/Fe3+ nanoparticles eradicate intratumoral bacteria and activate ferroptosis for enhanced antitumor immunotherapy in breast cancer (2025 · Biomaterials · 被引 8)
In vitro screening of synbiotics based on a four-strain probiotic blend and their therapeutic potential for ulcerative colitis (2025 · Biomedicine & Pharmacotherapy · 被引 7)
Biomaterial design strategies for enhancing mitochondrial transplantation therapy (2025 · BMEMat · 被引 6)
Synergistic chemodynamic and metabolic reprogramming-based cancer therapy by CuO@HA nanozymes with oxygen vacancy (2025 · Theranostics · 被引 5)
Spatially heterogeneous microgel-annealed PRP-derived fibrin hydrogel promotes coordinated vasculogenesis and angiogenesis after myocardial infarction (2026 · Acta Biomaterialia · 被引 3)
Research on the immunological activity of a bioavailable active peptide KSPLY from Hericium erinaceus under different immune scenarios (2025 · Chemical Engineering Journal · 被引 3)